| Eskridge Care And Rehab | |
| 505 N. Main Street, Eskridge, Kansas 66423 | |
| (785) 449-2294 | |
| Name | Eskridge Care And Rehab |
|---|---|
| Location | 505 N. Main Street, Eskridge, Kansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 91.33% |
| Medicare ID (CCN) | 175455 |
| Legal Business Name | Eskridge Operator Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1083263040 |
| Organization Name | ESKRIDGE OPERATOR, LLC |
| Address | 505 N Main St, Eskridge, KS 66423 |
| Phone Number | 785-449-2294 |
News Archive
Every week in Murfreesboro, Tenn., Zibin Guo guides veterans in wheelchairs through slow-motion tai chi poses as a Bluetooth speaker plays soothing instrumental music.
While we are often exposed to bacteria in our food which could cause food poisoning, we don't always become ill - why should this be so?
Representing excellence and innovation in the field of healthcare, BMI Healthcare has been shortlisted as a finalist in the IT Innovator of the Year category of this year's HealthInvestor Awards.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
According to a nationwide analysis of physician visit records conducted by a team of researchers at Harvard Medical School and the RAND Corporation, nearly 30 percent of the outpatient opioid prescriptions made out in the United States do not have documented justification for their use.
› Verified 9 days ago
| NPI Number | 1093263626 |
| Organization Name | ESKRIDGE CARE AND REHABILITATION CENTER, LLC |
| Address | 505 N Main St, Eskridge, KS 66423 |
| Phone Number | 785-449-2294 |
News Archive
Every week in Murfreesboro, Tenn., Zibin Guo guides veterans in wheelchairs through slow-motion tai chi poses as a Bluetooth speaker plays soothing instrumental music.
While we are often exposed to bacteria in our food which could cause food poisoning, we don't always become ill - why should this be so?
Representing excellence and innovation in the field of healthcare, BMI Healthcare has been shortlisted as a finalist in the IT Innovator of the Year category of this year's HealthInvestor Awards.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
According to a nationwide analysis of physician visit records conducted by a team of researchers at Harvard Medical School and the RAND Corporation, nearly 30 percent of the outpatient opioid prescriptions made out in the United States do not have documented justification for their use.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Every week in Murfreesboro, Tenn., Zibin Guo guides veterans in wheelchairs through slow-motion tai chi poses as a Bluetooth speaker plays soothing instrumental music.
While we are often exposed to bacteria in our food which could cause food poisoning, we don't always become ill - why should this be so?
Representing excellence and innovation in the field of healthcare, BMI Healthcare has been shortlisted as a finalist in the IT Innovator of the Year category of this year's HealthInvestor Awards.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
According to a nationwide analysis of physician visit records conducted by a team of researchers at Harvard Medical School and the RAND Corporation, nearly 30 percent of the outpatient opioid prescriptions made out in the United States do not have documented justification for their use.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $21031 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.64 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.57 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 13.07 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.34 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.4 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.71 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 75.57 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 97.14 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 46.15 | 83.88 |